CarthaGenetics® provides consulting international services to Orphan Drugs companies who want to expand not only in Western Europe but also in the fast-growing Turkish and North African markets.
Early revenues planning and generation. Competitive Intelligence. Market research, landscaping and benchmarking activities. Regulatory consulting. Patient identification. CarthaGenetics® is NOT a CRO, but collaborates with.
- +41 22 575 31 31
- Philippe Carteron de Balmont